RaQualia moves provide year-end succor
This article was originally published in Scrip
Executive Summary
Following the drastic cuts to its sales and profit forecasts for calendar 2013 in early November, RaQualia Pharma has taken two steps that will contribute to its business, one providing an immediate boost before the books close for the year.